|drug416||Behaviour Change Technique Intervention to Improve Quality of Life Wiki||1.00|
|D015775||Fractures, Stress NIH||0.71|
|D000068376||Compassion Fatigue NIH||0.71|
|D000067073||Psychological Trauma NIH||0.71|
There is one clinical trial.
The Professional Peer Resilience Initiative (PPRI) study is an observational study aimed at understanding how symptoms of traumatic stress and resilience evolve over time in the University of Minnesota (UMN) healthcare workforce during the coronavirus disease 2019 (COVID-19) pandemic. The study is being conducted concurrently with a UMN peer support program called the MinnRAP program and will remotely administer quality of life and mental health surveys to healthcare workers before they start the MinnRAP program and throughout their participation in the program.
Description: Professional Quality of Life Questionnaire (proQOL): min score of 10; max score of 50; higher scores mean worse outcomeMeasure: Change in professional quality of life Time: Before peer support program, through study completion (an average of 7 months)
Description: Stress Risk & Resilience Self-Index: min score 0; max score of 12; higher scores mean worse outcomeMeasure: Change in mental health symptoms and resilience markers Time: Before peer support program, through study completion (an average of 7 months)
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports